期刊文献+

脑血管支架植入术后再狭窄患者血清S1P、HC-Ⅱ水平与血管活性物质、细胞因子的关系 被引量:1

Relationship of serum S1P and HC-Ⅱ levels with vasoactive substances and cytokines in patients with cerebral vascular restenosis after stent implantation
暂未订购
导出
摘要 目的:探讨脑血管支架植入术后再狭窄患者血清S1P、HC-Ⅱ水平与血管活性物质、细胞因子的关系。方法:收集在本院接受脑血管支架植入术且出现再狭窄的患者52例作为观察组,另取同期在本院进行复查的健康脑血管支架植入术后患者40例作为对照组。采用ELISA法检测血清S1P、HC-Ⅱ水平及血管活性物质、炎症因子含量。采用Spearman相关分析评估血清S1P、HC-Ⅱ水平与血管活性物质、炎症因子的关系。结果:观察组血清S1P、HC-Ⅱ水平低于对照组(P<0.05);观察组血清中血管活性物质ET、AngⅡ、TXB2含量高于对照组,NO含量低于对照组(P<0.05);观察组血清炎症因子hs-CRP、IL-1、IL-6、IL-8、IL-11含量高于对照组(P<0.05)。脑血管支架植入术后再狭窄患者血清S1P、HC-Ⅱ水平与血管活性物质、炎症因子含量存在直接相关关系。结论:脑血管支架植入术后再狭窄患者血清S1P、HC-Ⅱ水平降低,是导致脑血管功能异常、全身炎症反应的重要原因。 Objective:To study the relationship of serum S1 Pand HC-Ⅱ levels with vasoactive substances and cytokines in patients with cerebral vascular restenosis after stent implantation.Methods:A total of 52 patients who received cerebrovascular stent implantation and developed restenosis in our hospital between May 2012 and December 2015 were collected as observation group,and 40 healthy patients with cerebrovascular stent implantation who had re-examination in our hospital during the same period were selected as control group.ELISA method was used to detect serum S1 Pand HC-Ⅱ levels as well as vasoactive substance and inflammatory factor contents.Spearman correlation analysis was used to evaluate the relationship of serum S1 P and HC-Ⅱ levels with vasoactive substances and inflammatory factors.Results:Serum S1 Pand HC-Ⅱ levels of observation group were lower than those of control group(P〈0.05);serum vasoactive substances ET,AngⅡ and TXB2 contents of observation group were higher than those of control group while NO content was lower than that of control group(P〈0.05);serum inflammatory factors hs-CRP,IL-1,IL-6,IL-8and IL-11 contents of observation group were higher than those of control group(P〈0.05).Serum S1 Pand HC-Ⅱ levels in patients with cerebral vascular restenosis after stent implantation were directly correlated with vasoactive substance and inflammatory factor contents.Conclusions:Serum S1 Pand HC-Ⅱ levels decrease in patients with cerebral vascular restenosis after stent implantation,and it is an important cause of cerebral vascular dysfunction and systemic inflammatory response.
作者 刘勇
出处 《海南医学院学报》 CAS 2017年第7期966-968,972,共4页 Journal of Hainan Medical University
基金 重庆市万州区科技计划项目(KJ20130108)~~
关键词 脑血管支架植入术 1-磷酸鞘氨醇 肝素辅因子Ⅱ 血管活性物质 Cerebrovascular stent implantation Sphingosine 1-phosphate Heparin cofactorⅡ Vasoactive substances
  • 相关文献

参考文献8

二级参考文献93

  • 1李洪军.血栓栓塞性疾病患者抗凝血酶-Ⅲ的水平测定及意义[J].继续医学教育,2010,24(6):82-83. 被引量:3
  • 2郭维琴.中医药防治PTCA后RS的研究[J].中医药学刊,2005,23(9):1549-1550. 被引量:26
  • 3Turak O,Ozcan F, Isleyen A, et al. Usefulness of the neutro phil-to lymphocyte ratio to predict bare-metal stent resteno- sis. Am J Cardiol,2012,110:1405-1410.
  • 4Gabbasov ZA, Kozlov SG, Saburova OS, et al. Eosinophilic cation protein and development of restenosis of drug covered stents. Kardiologiia, 2011,51 : 49-54.
  • 5Marfella R, Sasso FC, Siniscalchi M, et al. Peri-procedural tight glycemic control during early pereutaneous coronary in- tervention is associated with a lower rate of in-stent restenosis in patients with acute ST-elevation myocardial infarction. J Clin Endocrinol Metab, 2012,97 : 2862 2871.
  • 6Hasokawa M, Shinohara M, Tsugawa H, et al. Identification of biomarkers of stent restenosis with serum metabolic profi- ling using gas chromatography/mass spectrometry. Circ J, 2012,76 : 1864-1873.
  • 7Katsaros KM, Wiesbauer F, Speidl WS, et al. High solubleFas and soluble Fas ligand serum levels before stent implanta- tion are protective against restenosis. Thromb Haemost, 2011,105 ..883-891.
  • 8Shuvalova YA, Kaminnyi AI, Meshkov AN, et al. Association between polymorphisms of eNOS and GPx 1 genes,activity of free-radical processes and iwstent restenosis. Mol Cell Bio- chem,2012,370.. 241 249.
  • 9Tahir H, Hoekstra AG, Lorenz E,et al. Multi-scale simula tions of the dynamics of in stent restenosis: impact of stent deployment and design. Interface Focus, 2011,1 .. 365-373.
  • 10Habara M, Terashima M, Nasu K, et al. Morphological differ ences of tissue characteristics between early, late, and very late restenosis lesions after first generation drug eluting stent implantation: an optical coherence tomography study. Eur Heart J Cardiovasc Imaging, 2013,14 ~ 276-284.

共引文献55

同被引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部